Sumitomo Dainippon Pharma Co Ltd - Total Revenue

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Total-Revenue" stands at 445.20 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 09/30/2023.

Sumitomo Dainippon Pharma Co Ltd's second quarter result of 119.12 Billion JPY for the item "Total Revenue" represents an increase of 10.29 percent compared to it's first quarter result.

Also, Sumitomo Dainippon Pharma Co Ltd's second quarter result of 119.12 Billion JPY for the item "Total Revenue" represents an increase of 32.25 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sumitomo Dainippon Pharma Co Ltd's second quarter result of 445.20 Billion JPY for the item "Total Revenue" represents an increase of 6.98 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 29.92 percent compared to the value the year prior.
The 1 year change in percent is 29.92.
The 3 year change in percent is -23.97.
The 5 year change in percent is -13.32.
The 10 year change in percent is 13.57.

The Serie's long term average value is 430.77 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 3.35 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is +41.53%.
The Serie's change in percent from it's maximum value, on 06/30/2022, to it's latest available value, on 09/30/2025, is -24.38%.